168 related articles for article (PubMed ID: 18071319)
21. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Squires MS; Nixon PM; Cook SJ
Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
[TBL] [Abstract][Full Text] [Related]
22. Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.
Pereira DM; Rodrigues CMP
Trends Mol Med; 2020 Apr; 26(4):394-407. PubMed ID: 32277933
[TBL] [Abstract][Full Text] [Related]
23. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
Diéguez-Martínez N; Espinosa-Gil S; Yoldi G; Megías-Roda E; Bolinaga-Ayala I; Viñas-Casas M; Gorgisen G; Domingo-Ortí I; Pérez-Montoyo H; Bayascas JR; Colas E; Dolcet X; Lizcano JM
Cell Mol Life Sci; 2022 Sep; 79(10):524. PubMed ID: 36123565
[TBL] [Abstract][Full Text] [Related]
24. The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.
Bobick BE; Matsche AI; Chen FH; Tuan RS
J Cell Physiol; 2010 Jul; 224(1):178-86. PubMed ID: 20232315
[TBL] [Abstract][Full Text] [Related]
25. Extracellular Signal-Regulated Kinase 5 is Required for Low-Concentration H
Jiang S; Zhang D; Huang H; Lei Y; Han Y; Han W
Biomed Res Int; 2017; 2017():6895730. PubMed ID: 28540300
[No Abstract] [Full Text] [Related]
26. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
28. c-myc Promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway.
Ghosh AK; Steele R; Ray RB
J Biol Chem; 2005 Apr; 280(14):14325-30. PubMed ID: 15805119
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Tusa I; Menconi A; Tubita A; Rovida E
Cells; 2023 Apr; 12(8):. PubMed ID: 37190064
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.
Cavanaugh JE; Ham J; Hetman M; Poser S; Yan C; Xia Z
J Neurosci; 2001 Jan; 21(2):434-43. PubMed ID: 11160424
[TBL] [Abstract][Full Text] [Related]
32. Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents.
Broustas CG; Duval AJ; Chaudhary KR; Friedman RA; Virk RK; Lieberman HB
Oncogene; 2020 Mar; 39(12):2467-2477. PubMed ID: 31980741
[TBL] [Abstract][Full Text] [Related]
33. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
Simões AE; Rodrigues CM; Borralho PM
Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
[TBL] [Abstract][Full Text] [Related]
34. PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway.
Nakamura K; Johnson GL
J Biol Chem; 2003 Sep; 278(39):36989-92. PubMed ID: 12912994
[TBL] [Abstract][Full Text] [Related]
35. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
[TBL] [Abstract][Full Text] [Related]
36. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.
Wang X; Merritt AJ; Seyfried J; Guo C; Papadakis ES; Finegan KG; Kayahara M; Dixon J; Boot-Handford RP; Cartwright EJ; Mayer U; Tournier C
Mol Cell Biol; 2005 Jan; 25(1):336-45. PubMed ID: 15601854
[TBL] [Abstract][Full Text] [Related]
37. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
38. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic signaling of MEK5-ERK5.
Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
[TBL] [Abstract][Full Text] [Related]
40. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
